Systemic Lupus Erythematosus Nephritis

1

Review clinical trials related to Systemic Lupus Erythematosus Nephritis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Monitoring Lupus Nephritis Through Urinary Extracellular Vesicles

Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE) that can lead to irreversible kidney damage if not detected and managed promptly. LN is classified and treated based on its histopathological features obtained by invasive kidney biopsy. Recent research has suggested urinary extracellular vesicles (uEVs) as potential non-invasive biomarkers. The primary objective of this prospective study is to investigate the utility of uEVs in LN.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Kolding SygehusUpdated: Sep 9, 2025Locations: 4Duration: 1 Year
Eligibility criteria

> 18 years old [+3]

Lack of ability or willingness to provide informed consent [+19]